caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1720195613

Deirdre Stegman

PRACTICEPALO ALTO MEDICAL FOUNDATIONSee all providers at this practice →
Internal MedicinePalo Alto, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Deirdre Stegman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jon Keller
Pathology · Palo Alto, CA
152612
Joseph Walter
Diagnostic Radiology · Palo Alto, CA
3249
Susan Ryu
Ophthalmology · Stanford, CA
1422
Cheena Ramrakhiani
Cardiology · Stanford, CA
1213
Rita Sohlich
Diagnostic Radiology · Palo Alto, CA
1119
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
298
Beneficiaries
—
Total drug cost
$18K
Distinct drugs
11
Brand share
15.4%
Top prescribed drugs
Atorvastatin Calcium83 claims
Amlodipine Besylate44 claims
Losartan Potassium34 claims
Levothyroxine Sodium31 claims
Lisinopril21 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.